For example, Eberhardt et al., using the tissue microarray (TMA), found moderate and high SATB2-Ir in the majority of 527 analyzed incident colon and rectal cancers, while 28.8% of patients presented negative SATB2 staining [23]. This evidence concerns the gene SATB2 and rectal cancer.